Literature DB >> 28932537

The role of video-assisted thoracoscopic surgery for management of symptomatic pleural effusion after coronary artery bypass surgery: a best evidence topic report.

Alfonso Fiorelli1, Francesco Caronia2, Aldo Prencipe3, Mario Santini1, Brendon Stiles4.   

Abstract

A best evidence topic in thoracic surgery was written addressing whether video-assisted thoracoscopic surgery (VATS) talc pleurodesis could be justified in patients with pleural effusion (PE) after coronary artery bypass graft (CABG) surgery and no-responded to repeated thoracentesis. Ten papers were identified to answer the question. Of these, two were case-series study including ≥4 patients, 7 retrospective analytical studies, and one observational study but no randomized controlled trial (RCTs) was included in the analysis. The score of the level of evidence was low; only one study presented a level of evidence of 2, 7 studies a level of 3b; and two studies a level of evidence of 4. The incidence of symptomatic post-CABG PE ranged from 2% to 9.7%. Management strategies included medical management, thoracentesis, and/or surgical drainage. Most of the authors treated early and late PE with thoracentesis or chest drainage, while VATS with pleurodesis was reserved only for selected patients with persistent effusion after repeating thoracentesis and/or chest drainage. All studies but one do not include follow-up, thus rendering it difficult to define the real role of thoracentesis or chest drainage as definitive treatments for effusion, given the incomplete data regarding how many patients' effusions recur. Conversely, with follow up reported, no case of recurrence was found after VATS procedure. In patients who underwent delayed VATS, it was common to identify the formation of tenacious peel that trapped the lung. In three cases conversion to thoracotomy was required to decorticate the inflammatory peel that covered the pleura and did not allow the lung re-expansion. However, only five papers showed that VATS for management of post-CABG PEs is safe and efficacious and its use could help to prevent trapped lung through the resection of adhesions and loculations sometimes associated with multiple previous thoracentesis or chest drainage. As the low grade of evidence from the present analysis, future randomized controlled studies are wanted to define the real effectiveness of VATS in this field.

Entities:  

Keywords:  Pleural effusion (PE); coronary artery bypass graft surgery (CABG surgery); video-assisted thoracoscopic surgery (VATS)

Year:  2017        PMID: 28932537      PMCID: PMC5594165          DOI: 10.21037/jtd.2017.06.119

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  10 in total

1.  Prevalence of symptomatic large pleural effusions first diagnosed more than 30 days after coronary artery bypass graft surgery.

Authors:  Ming-Cheng Peng; Charles Jia-Yin Hou; Jiun-Yi Li; Po-Yuan Hu; Chun-Yen Chen
Journal:  Respirology       Date:  2007-01       Impact factor: 6.424

2.  Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery.

Authors:  R T Sadikot; J T Rogers; D S Cheng; P Moyers; M Rodriguez; R W Light
Journal:  Arch Intern Med       Date:  2000-09-25

3.  Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery.

Authors:  Richard W Light; Jeffrey T Rogers; J Phillip Moyers; Y C Gary Lee; R Michael Rodriguez; William C Alford; Stephen K Ball; George R Burrus; William H Coltharp; David M Glassford; Steven J Hoff; John W Lea; Jonathan C Nesbitt; Michael R Petracek; Thomas D Starkey; William S Stoney; Mark Tedder
Journal:  Am J Respir Crit Care Med       Date:  2002-10-11       Impact factor: 21.405

4.  Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment : clinical and histologic features.

Authors:  Y C Lee; M A Vaz; K A Ely; E C McDonald; P J Thompson; J C Nesbitt; R W Light
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

5.  Pleuropulmonary morbidity: internal thoracic artery versus saphenous vein graft.

Authors:  D Hurlbut; M L Myers; M Lefcoe; M Goldbach
Journal:  Ann Thorac Surg       Date:  1990-12       Impact factor: 4.330

Review 6.  The spectrum of pleural effusions after coronary artery bypass grafting surgery.

Authors:  Jay Heidecker; Steven A Sahn
Journal:  Clin Chest Med       Date:  2006-06       Impact factor: 2.878

7.  Persistent symptomatic pleural effusion following coronary bypass surgery: clinical and histologic features, and treatment.

Authors:  Jean-Christophe Charniot; Khaled Zerhouni; Marianne Kambouchner; Emmanuel Martinod; Noëlle Vignat; Jacques Azorin; Iradj Gandjbakhch; Jean-Yves Artigou
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

8.  Thoracoscopic talc pleurodesis for recurrent, symptomatic pleural effusion following cardiac operations.

Authors:  Douglas E Paull; Thomas J Delahanty; Fred J Weber; Michael D Harostock
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2003-10       Impact factor: 1.719

9.  Delayed pleuropulmonary complications following coronary artery revascularization with the internal mammary artery.

Authors:  M H Kollef; T Peller; A Knodel; W H Cragun
Journal:  Chest       Date:  1988-07       Impact factor: 9.410

10.  Pleural effusions following cardiac surgery: prevalence, risk factors, and clinical features.

Authors:  Moujahed Labidi; Richard Baillot; Brigitte Dionne; Yves Lacasse; François Maltais; Louis-Philippe Boulet
Journal:  Chest       Date:  2009-07-06       Impact factor: 9.410

  10 in total
  1 in total

1.  Video-Assisted Thoracoscopic Surgery Management of Subacute Retained Blood Syndrome after Cardiac Surgery.

Authors:  Vasileios Drosos; Koray Durak; Rüdiger Autschbach; Jan Spillner; Katharina Nubbemeyer; Rashad Zayat; Sebastian Kalverkamp
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-10-23       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.